| Ytd | -81.95% | |
| 1y | -83.53% |
| Open | 2.42 | Prev Close | 2.31 | Low | 2.18 | High | 2.45 | Mkt Cap | 155.83M |
| Vol | 21.46K | Avg Vol | 33.51K | EPS | -0.12 | P/E | N/A | Forward P/E | N/A |
| Beta | 0.16 | Short Ratio | 0.77 | Inst. Own | 0.35% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 4.00 | 200-d Avg | 9.74 | 1yr Est | 0.00 |
YDES News
Taipei, Taiwan, July 02, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited ("YD Bio" or the "Company") (Nasdaq
Gainers HeartSciences (NASDAQ:HSCS) stock rose 82.2% to $3.23 during Tuesday's pre-market sessi
The Dow Jones index rose 700 points, Autoliv Inc (NYSE: ALV) reported strong results causing a jump
Stocks fall, Nasdaq drops 200 points. Apogee Therapeutics (APGE) rises 19.4% on positive trial data.
YD Bio Limited ("YD Bio Ltd" or the "Company") (NASDAQ:YDES), a biotechnology compan
YD Bio Limited ("YD Bio" or the "Company") (Nasdaq: YDES), a biotechnology company a
YD Bio Limited ("YD Bio" or the "Company") (Nasdaq: YDES), a biotechnology company a
YD Bio Limited ("YD Bio" or the "Company") (NASDAQ:YDES), a biotechnology company ad
YD Bio Limited ("YD Bio" or the "Company") (NASDAQGM:YDES), a biotechnology company
YD Bio Limited ("YD Bio" or the "Company") (NASDAQ:YDES), a biotechnology company ad
On September 24, 2025, Ms. May Tsai, Chief Operating Officer of YD Bio Limited (the "Company"
U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Friday.
